Expression	O
of	O
epidermal	O
growth	O
factor	O
receptor	O
,	O
transforming	O
growth	O
factor	O
-	O
alpha	O
and	O
Ki	O
-	O
67	O
in	O
relationship	O
to	O
malignant	O
transformation	O
of	O
pleomorphic	B-Pathological_formation
adenoma	I-Pathological_formation
.	O

CONCLUSION	O
:	O
Quantitative	O
assessment	O
is	O
more	O
sensitive	O
as	O
a	O
measure	O
of	O
cellular	B-Cell
protein	O
content	O
as	O
compared	O
with	O
standard	O
optical	O
density	O
measurements	O
.	O

The	O
data	O
support	O
the	O
hypothesis	O
that	O
increased	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
and	O
transforming	O
growth	O
factor	O
(	O
TGF	O
)	O
-	O
alpha	O
expression	O
is	O
associated	O
with	O
early	O
events	O
in	O
malignant	O
transformation	O
of	O
pleomorphic	B-Pathological_formation
adenoma	I-Pathological_formation
(	O
PA	B-Pathological_formation
)	O
.	O

OBJECTIVE	O
:	O
In	O
the	O
present	O
study	O
,	O
we	O
attempted	O
to	O
identify	O
EGFR	O
and	O
TGF	O
-	O
alpha	O
expression	O
and	O
Ki	O
-	O
67	O
index	O
in	O
carcinoma	B-Cancer
ex	I-Cancer
-	I-Cancer
pleomorphic	I-Cancer
adenoma	I-Cancer
(	O
Ca	B-Cancer
ex	I-Cancer
-	I-Cancer
PA	I-Cancer
)	O
and	O
PA	B-Pathological_formation
.	O

We	O
also	O
compared	O
the	O
presence	O
of	O
EGFR	O
and	O
TGF	O
-	O
alpha	O
and	O
Ki	O
-	O
67	O
index	O
with	O
clinical	O
data	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
The	O
tissues	B-Tissue
were	O
stained	O
with	O
monoclonal	O
antibodies	O
to	O
EGFR	O
,	O
TGF	O
-	O
alpha	O
and	O
Ki	O
-	O
67	O
.	O

The	O
results	O
were	O
analysed	O
using	O
quantitative	O
immunohistochemical	O
analysis	O
.	O

We	O
also	O
analysed	O
the	O
association	O
of	O
patients	O
'	O
prognosis	O
with	O
clinical	O
parameters	O
and	O
the	O
histological	O
classification	O
of	O
the	O
carcinomatous	B-Cancer
component	I-Cancer
.	O

RESULTS	O
:	O
As	O
regards	O
the	O
association	O
of	O
patients	O
'	O
prognosis	O
with	O
EGFR	O
staining	O
and	O
Ki	O
-	O
67	O
index	O
,	O
a	O
significant	O
increase	O
was	O
observed	O
in	O
patients	O
who	O
died	O
or	O
had	O
residual	O
disease	O
compared	O
with	O
patients	O
who	O
were	O
alive	O
without	O
disease	O
.	O

In	O
the	O
immunohistochemical	O
analysis	O
of	O
EGFR	O
and	O
TGF	O
-	O
alpha	O
and	O
Ki67	O
index	O
,	O
a	O
significant	O
increase	O
was	O
observed	O
in	O
Ca	B-Cancer
ex	I-Cancer
-	I-Cancer
PA	I-Cancer
,	O
especially	O
with	O
adenocarcinoma	B-Cancer
,	O
compared	O
with	O
PA	B-Pathological_formation
and	O
sialadenitis	O
.	O

